The Patent Finder
KB

Kashiv Biosciences, LLC

First filing 2013
OverviewNotableFeesChangesFamiliesPatent listSources & methods

10 patents currently held

25 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in May 2041. from the record

Of the 25 now held by other companies, 21 name Amneal Complex Products Research LLC as their current owner, and 4 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2041
Next term end
7
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
Granted 2020. Computed term ends 2039. A terminal disclaimer caps this term to an earlier patent's.
Ends Jun 2039 · High confidence
Also notable
A family of 8 related applications built on the 2022 grant. Protection runs to 2038. A terminal disclaimer caps this term to an earlier patent's.
Ends Jun 2038 · Medium confidence
Also notable
Granted 2016 and renewed at every maintenance window due so far. Protection runs to 2035.
Ends May 2035 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 16, 2027.

Recent changes

What they patent

The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 10 of 10

PatentTitleStatusExpiresConfidence
US 12,139,510Process of Purification of Protein
In force
 · High confidence
In forceHigh confidence
US 12,378,282Process of Purification of Protein
In force
 · High confidence
In forceHigh confidence
US 12,435,106Process of Purification of Protein
In force
 · Medium confidence
In forceMedium confidence
US 12,600,747Process of Purification of Protein
In force
 · Medium confidence
In forceMedium confidence
US 12,767,686Separation of Pre-Peak and Post-Peak in Fusion Protein Sample by Using Size Exclusion High Performance Liquid Chromatography
In force
 · High confidence
In forceHigh confidence
US 12,710,424An Extraction Process of Pancrelipase and Evaluation Thereof
In force
 · High confidence
In forceHigh confidence
US 12,440,534Stable Ready to Dilute Composition of Carfilzomib
In force
 · Medium confidence
In forceMedium confidence
US 12,698,345A Process for Improving Omalizumab Expression in Cho Cells
In force
 · High confidence
In forceHigh confidence
US 12,352,759Assay Method of Antibody
In force
 · High confidence
In forceHigh confidence
US 12,760,062An Improved Process of Storing and Preparing the Protein
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 25 patents in force now held by others · 1 patent ended · 42 applications pending · 14 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
3 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
1 computed term date comes from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited